Ka. Kern et al., CARCINOGENIC POTENTIAL OF SILICONE BREAST IMPLANTS - A CONNECTICUT STATEWIDE STUDY, Plastic and reconstructive surgery, 100(3), 1997, pp. 737-747
To clarify the carcinogenic potential of silicone breast implants, 680
implant procedures performed on women in Connecticut with no prier hi
story of cancer were correlated with the subsequent development of pri
mary breast and nonbreast cancers. Neoplastic events after the placeme
nt of silicone breast implants during the 13-year interval from Octobe
r 1, 1980, through September 30, 1993, were quantified using a retrosp
ective, linked-registry method. ICD-9-CM discharge codes contained in
the Uniformed Hospital Discharge Data Sets (UHDDS) from 34 hospitals a
cross Connecticut were linked to procedure codes for unilateral and bi
lateral implants, and to medical histories for new malignancies after
the implant procedures. Data were cross-linked to the Connecticut Tumo
r Registry to confirm the clinical history of each cancer. The rates o
f breast and nonbreast cancers in patients with silicone br east impla
nts were compared with those of a control population drawn from the UH
DDS of 1022 women undergoing sterilization by tubal ligation between 1
981 to 1985. Ages (mean +/- SD) were similar in the implant group (34
+/- 10 years) and in the sterilization group (32 +/- 6 years). The mea
n follow-up in the implant group (4.6 years) was also similar to that
of the control group (5.4 years). Compared with the control group, the
implant group demonstrated lower rates of breast cancer (0.59 versus
0.88 percent, p = 0.35) and nonbreast cancer (0.59 versus 2.7 percent,
p = 0.001). Correspondingly, the implant group had a lower relative r
isk of breast cancel(relative risk = 0.67, 95 percent, confidence inte
rval = 0.20 to 2.17) and nonbreast cancer (relative risk = 0.21, 95 pe
rcent, confidence interval = 0.07 to 0.60). Based on these data, it wa
s concluded that silicone breast implants are not carcinogenic, becaus
e they are not associated with increased rates of either breast or non
breast cancers. The validity and threats to the conclusions are discus
sed, and the results are placed into contest with similar findings fro
m other studies.